181 related articles for article (PubMed ID: 24075516)
1. Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer.
Partecke LI; Günther C; Hagemann S; Jacobi C; Merkel M; Sendler M; van Rooijen N; Käding A; Nguyen Trung D; Lorenz E; Diedrich S; Weiss FU; Heidecke CD; von Bernstorff W
Pancreatology; 2013; 13(5):508-16. PubMed ID: 24075516
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration.
Zhang Y; Sime W; Juhas M; Sjölander A
Eur J Cancer; 2013 Oct; 49(15):3320-34. PubMed ID: 23810249
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer.
Griesmann H; Drexel C; Milosevic N; Sipos B; Rosendahl J; Gress TM; Michl P
Gut; 2017 Jul; 66(7):1278-1285. PubMed ID: 27013602
[TBL] [Abstract][Full Text] [Related]
4. Rejection of intradermally injected syngeneic tumor cells from mice by specific elimination of tumor-associated macrophages with liposome-encapsulated dichloromethylene diphosphonate, followed by induction of CD11b(+)/CCR3(-)/Gr-1(-) cells cytotoxic against the tumor cells.
Takahashi T; Ibata M; Yu Z; Shikama Y; Endo Y; Miyauchi Y; Nakamura M; Tashiro-Yamaji J; Miura-Takeda S; Shimizu T; Okada M; Ueda K; Kubota T; Yoshida R
Cancer Immunol Immunother; 2009 Dec; 58(12):2011-23. PubMed ID: 19365632
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor-induced skin carcinogenesis depends on recruitment and alternative activation of macrophages.
Linde N; Lederle W; Depner S; van Rooijen N; Gutschalk CM; Mueller MM
J Pathol; 2012 May; 227(1):17-28. PubMed ID: 22262122
[TBL] [Abstract][Full Text] [Related]
6. Liposome encapsulated zoledronate favours M1-like behaviour in murine macrophages cultured with soluble factors from breast cancer cells.
Sousa S; Auriola S; Mönkkönen J; Määttä J
BMC Cancer; 2015 Jan; 15():4. PubMed ID: 25588705
[TBL] [Abstract][Full Text] [Related]
7. Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity.
Péron JM; Bureau C; Gourdy P; Lulka H; Souque A; Calippe B; Selves J; Al Saati T; Bernad J; Cordelier P; Couderc B; Pradayrol L; Pipy B; Buscail L; Vinel JP
Gut; 2007 Jan; 56(1):107-14. PubMed ID: 16891358
[TBL] [Abstract][Full Text] [Related]
8. Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model.
Partecke LI; Käding A; Trung DN; Diedrich S; Sendler M; Weiss F; Kühn JP; Mayerle J; Beyer K; von Bernstorff W; Heidecke CD; Keßler W
Oncotarget; 2017 Apr; 8(14):22501-22512. PubMed ID: 28160574
[TBL] [Abstract][Full Text] [Related]
9. Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade.
Partecke LI; Speerforck S; Käding A; Seubert F; Kühn S; Lorenz E; Schwandke S; Sendler M; Keßler W; Trung DN; Oswald S; Weiss FU; Mayerle J; Henkel C; Menges P; Beyer K; Lerch MM; Heidecke CD; von Bernstorff W
Pancreatology; 2016; 16(3):423-33. PubMed ID: 27083074
[TBL] [Abstract][Full Text] [Related]
10. Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach.
Zeisberger SM; Odermatt B; Marty C; Zehnder-Fjällman AH; Ballmer-Hofer K; Schwendener RA
Br J Cancer; 2006 Aug; 95(3):272-81. PubMed ID: 16832418
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of murine alternatively activated macrophages.
Weisser SB; McLarren KW; Kuroda E; Sly LM
Methods Mol Biol; 2013; 946():225-39. PubMed ID: 23179835
[TBL] [Abstract][Full Text] [Related]
12. Tumour-educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion.
Karnevi E; Andersson R; Rosendahl AH
Immunol Cell Biol; 2014 Jul; 92(6):543-52. PubMed ID: 24662521
[TBL] [Abstract][Full Text] [Related]
13. RAW 264.7 Macrophage Polarization by Pancreatic Cancer Cells - A Model for Studying Tumour-promoting Macrophages.
Khabipov A; Käding A; Liedtke KR; Freund E; Partecke LI; Bekeschus S
Anticancer Res; 2019 Jun; 39(6):2871-2882. PubMed ID: 31177125
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of tumor-associated macrophages in pancreatic neuroendocrine tumors.
Krug S; Abbassi R; Griesmann H; Sipos B; Wiese D; Rexin P; Blank A; Perren A; Haybaeck J; Hüttelmaier S; Rinke A; Gress TM; Michl P
Int J Cancer; 2018 Oct; 143(7):1806-1816. PubMed ID: 29696624
[TBL] [Abstract][Full Text] [Related]
15. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response.
Ong SM; Tan YC; Beretta O; Jiang D; Yeap WH; Tai JJ; Wong WC; Yang H; Schwarz H; Lim KH; Koh PK; Ling KL; Wong SC
Eur J Immunol; 2012 Jan; 42(1):89-100. PubMed ID: 22009685
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.
Ngambenjawong C; Cieslewicz M; Schellinger JG; Pun SH
J Control Release; 2016 Feb; 224():103-111. PubMed ID: 26772876
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages promote invasion while retaining Fc-dependent anti-tumor function.
Grugan KD; McCabe FL; Kinder M; Greenplate AR; Harman BC; Ekert JE; van Rooijen N; Anderson GM; Nemeth JA; Strohl WR; Jordan RE; Brezski RJ
J Immunol; 2012 Dec; 189(11):5457-66. PubMed ID: 23105143
[TBL] [Abstract][Full Text] [Related]
18. Nodal promotes the generation of M2-like macrophages and downregulates the expression of IL-12.
Wang XF; Wang HS; Zhang F; Guo Q; Wang H; Wang KF; Zhang G; Bu XZ; Cai SH; Du J
Eur J Immunol; 2014 Jan; 44(1):173-83. PubMed ID: 24114072
[TBL] [Abstract][Full Text] [Related]
19. In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages.
Ly LV; Baghat A; Versluis M; Jordanova ES; Luyten GP; van Rooijen N; van Hall T; van der Velden PA; Jager MJ
J Immunol; 2010 Sep; 185(6):3481-8. PubMed ID: 20713886
[TBL] [Abstract][Full Text] [Related]
20. Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer.
Wilson AJ; Saskowski J; Barham W; Khabele D; Yull F
Mol Cancer; 2015 Nov; 14():192. PubMed ID: 26552746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
